Affinity Asset Advisors »

Spyglass Pharma shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Spyglass Pharma shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Spyglass Pharma

Tip: Access up to 7 years of quarterly data

All positions including Spyglass Pharma held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spyglass Pharma by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.5M 250k 25.91

More positions owned by Affinity Asset Advisors

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Insmed Com Par $.01 (INSM)
Roivant Sciences SHS (ROIV)
Spyre Therapeutics Com New (SYRE)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Praxis Precision Medicines I Com New (PRAX)
Anaptysbio Inc Common (ANAB)
Alkermes SHS (ALKS)
Cytokinetics Com New (CYTK)
Abivax Sa Sponsored Ads (ABVX)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Arcellx Common Stock (ACLX)

View all positions for Affinity Asset Advisors

Top funds holding Spyglass Pharma

RA Capital Management
NEA Management Company
Sands Capital Ventures
Samsara BioCapital
Vestal Point Capital
Deerfield Management Company
Millennium Management
Vanguard Capital Management
First Light Asset Management
Franklin Resources
Affinity Asset Advisors
Standard Life Aberdeen
BlackRock
Geode Capital Management
Monashee Investment Management

View all funds holding Spyglass Pharma